Core Insights - Workday reported $2.35 billion in revenue for the quarter ended July 2025, marking a year-over-year increase of 12.6% and exceeding the Zacks Consensus Estimate by 0.35% [1] - The earnings per share (EPS) for the same period was $2.21, up from $1.75 a year ago, representing a surprise of 5.74% over the consensus estimate of $2.09 [1] Financial Performance Metrics - Subscription revenue backlog stood at $25.37 billion, below the average estimate of $26.48 billion [4] - Subscription services revenue was reported at $2.17 billion, slightly above the average estimate of $2.16 billion, reflecting a year-over-year increase of 14% [4] - Professional services revenue was $179 million, slightly below the average estimate of $180.17 million, indicating a year-over-year decline of 1.7% [4] Stock Performance - Workday's shares have returned -5.6% over the past month, contrasting with the Zacks S&P 500 composite's increase of 1.7% [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]

Core Insights - Sotera Health Company (SHC) reported revenue of $294.34 million for the quarter ended June 2025, reflecting a year-over-year increase of 6.4% [1] - The earnings per share (EPS) for the quarter was $0.20, up from $0.19 in the same quarter last year, exceeding the consensus EPS estimate of $0.17 by 17.65% [1] - The reported revenue surpassed the Zacks Consensus Estimate of $276.08 million, resulting in a surprise of 6.61% [1] Financial Performance Metrics - Sotera Health's segment revenues included Sterigenics at $194.84 million, exceeding the average estimate of $184.48 million by 10.5% year-over-year [4] - Nelson Labs reported revenues of $57.07 million, slightly above the average estimate of $56.73 million, but down 3.3% year-over-year [4] - Nordion's revenues were $42.43 million, surpassing the average estimate of $34.95 million with a year-over-year increase of 2.9% [4] Segment Income Analysis - Segment income for Sterigenics was reported at $107.75 million, exceeding the average estimate of $100.36 million [4] - Nelson Labs achieved segment income of $19.51 million, above the estimated $17.53 million [4] - Nordion's segment income was $23.48 million, significantly higher than the average estimate of $18.62 million [4] Stock Performance - Shares of Sotera Health have declined by 5.6% over the past month, contrasting with the Zacks S&P 500 composite's increase of 1.9% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Health Catalyst reported revenue of $80.72 million for the quarter ended June 2025, reflecting a 6.4% increase year-over-year, and an EPS of $0.04, down from $0.12 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $80.53 million by 0.24%, while the EPS surpassed the consensus estimate of $0.03 by 33.33% [1] Revenue Breakdown - Professional services revenue was $27.85 million, slightly below the average estimate of $27.86 million, representing a year-over-year decline of 1.5% [4] - Technology revenue reached $52.88 million, exceeding the estimated $52.67 million, and showing an 11% increase compared to the previous year [4] Profitability Metrics - Adjusted Gross Profit for Professional Services was reported at $5.11 million, surpassing the average estimate of $4.09 million [4] - Adjusted Gross Profit for Technology was $34.85 million, slightly below the average estimate of $35.35 million [4] Stock Performance - Over the past month, Health Catalyst shares have returned -5.2%, contrasting with a +1.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Core Insights - Service Properties (SVC) reported revenue of $503.44 million for the quarter ended June 2025, reflecting a year-over-year decline of 1.9% [1] - The earnings per share (EPS) for the same period was $0.35, a significant improvement from -$0.45 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $497.77 million by 1.14%, while the EPS surprise was 2.94% compared to the consensus estimate of $0.34 [1] Revenue Breakdown - Hotel operating revenues were $404.41 million, slightly above the average estimate of $397.67 million, but represented a year-over-year decline of 2% [4] - Rental income was reported at $99.03 million, which was below the average estimate of $100.12 million, showing a year-over-year decrease of 1.4% [4] Stock Performance - Over the past month, shares of Service Properties have returned +3.5%, outperforming the Zacks S&P 500 composite's +1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Financial Performance - Sun Country Airlines reported revenue of $263.62 million for the quarter ended June 2025, marking a year-over-year increase of 3.6% [1] - The earnings per share (EPS) for the same period was $0.14, compared to $0.06 a year ago, indicating significant growth [1] - The reported revenue exceeded the Zacks Consensus Estimate of $254.49 million, resulting in a surprise of +3.59% [1] - The company also delivered an EPS surprise of +16.67%, with the consensus EPS estimate being $0.12 [1] Key Metrics - Fuel cost per gallon was reported at $2.43, matching the two-analyst average estimate [4] - Total revenue per available seat mile (TRASM) was 11.26 cents, below the average estimate of 11.79 cents [4] - Available seat miles (ASMs) were reported at 1.57 million, slightly above the average estimate of 1.56 million [4] - Revenue passenger miles were 1.29 billion, aligning with the average estimate [4] - Adjusted cost per available seat mile (CASM) was 8.34 cents, compared to the estimated 8.5 cents [4] - Load factor was reported at 81.8%, below the average estimate of 82.5% [4] - Fuel gallons consumed were 20.95 million, exceeding the average estimate of 20.21 million [4] - Operating revenues from passenger services were $214.67 million, surpassing the estimated $209.43 million [4] - Other operating revenues were $14.15 million, above the average estimate of $12.67 million [4] - Cargo operating revenues reached $34.8 million, compared to the estimated $32.55 million [4] Stock Performance - Shares of Sun Country Airlines have returned -3.9% over the past month, contrasting with the Zacks S&P 500 composite's +2.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - CubeSmart (CUBE) reported revenue of $282.3 million for the quarter ended June 2025, reflecting a 6.1% increase year-over-year and surpassing the Zacks Consensus Estimate of $274.33 million by 2.91% [1] - The company's EPS for the quarter was $0.65, up from $0.41 in the same quarter last year, exceeding the consensus estimate of $0.63 by 3.17% [1] Financial Performance Metrics - Property management fee income was reported at $10.15 million, slightly below the estimated $10.66 million, representing a year-over-year decline of 3% [4] - Rental income reached $239.56 million, exceeding the average estimate of $233.37 million, with a year-over-year increase of 5.6% [4] - Other property-related income was $32.6 million, surpassing the estimated $29.86 million, marking a year-over-year growth of 12.6% [4] - Net Earnings Per Share (Diluted) was reported at $0.36, slightly below the estimated $0.37 [4] Stock Performance - CubeSmart's shares have returned -4.4% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Cognizant reported revenue of $5.25 billion for the quarter ended June 2025, reflecting an 8.1% increase year-over-year and surpassing the Zacks Consensus Estimate of $5.19 billion by 1.01% [1] - Earnings per share (EPS) for the quarter was $1.31, up from $1.17 in the same quarter last year, exceeding the consensus EPS estimate of $1.26 by 3.97% [1] Revenue Performance by Segment - Health Sciences revenue was $1.55 billion, slightly below the average estimate of $1.61 billion, representing a year-over-year increase of 6.2% [4] - Communications, Media and Technology revenue reached $841 million, exceeding the average estimate of $826.36 million, with a year-over-year growth of 3.1% [4] - Products and Resources generated $1.31 billion, surpassing the estimated $1.25 billion, marking a significant year-over-year increase of 16% [4] - Financial Services revenue was $1.55 billion, slightly above the average estimate of $1.52 billion, reflecting a year-over-year growth of 6.9% [4] Stock Performance - Cognizant's shares have declined by 6.9% over the past month, contrasting with the Zacks S&P 500 composite's increase of 3.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Controladora Vuela (VLRS) reported a revenue of $693 million for the quarter ended June 2025, reflecting a decrease of 4.6% year-over-year, with an EPS of -$0.54 compared to $0.09 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $666.74 million by 3.94%, while the EPS surprised positively by 28% against a consensus estimate of -$0.75 [1] Financial Performance Metrics - Available Seat Miles (ASMs) totaled $8.89 billion, slightly below the average estimate of $8.93 billion from two analysts [4] - The load factor was reported at 82.4%, lower than the average estimate of 85.2% [4] - Operating expenses per ASM (CASM) were 8.05 cents, slightly above the estimated 8.01 cents [4] - Fuel gallons accrued were 84.90 million, exceeding the average estimate of 83.14 million [4] - CASM excluding fuel was reported at 5.69 cents, marginally better than the average estimate of 5.71 cents [4] - Revenue Passenger Miles (RPMs) totaled $7.32 billion, below the estimated $7.61 billion [4] - Passenger revenues from fares were $285 million, significantly lower than the average estimate of $297.69 million, marking an 18.3% year-over-year decline [4] Stock Performance - Controladora Vuela's shares have returned +7.4% over the past month, outperforming the Zacks S&P 500 composite's +5.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Sprinklr reported revenue of $205.5 million for the quarter ended April 2025, marking a year-over-year increase of 4.9% and an EPS of $0.12 compared to $0.09 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $201.89 million by 1.79%, and the EPS surpassed the consensus estimate of $0.10 by 20% [1] Financial Performance Metrics - Gross Margin for Subscription was reported at 77%, above the five-analyst average estimate of 76.4% [4] - Gross Margin for Professional Services was 4%, compared to the two-analyst average estimate of -1% [4] - Subscription Revenue reached $184.13 million, exceeding the average estimate of $182.39 million by analysts, representing a year-over-year increase of 3.8% [4] - Professional Services Revenue was reported at $21.37 million, surpassing the average estimate of $19.49 million, reflecting a year-over-year change of 14.9% [4] Stock Performance - Sprinklr's shares have returned 17.1% over the past month, outperforming the Zacks S&P 500 composite's 5.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Agilent Technologies reported revenue of $1.67 billion for the quarter ended April 2025, reflecting a 6% increase year-over-year and exceeding the Zacks Consensus Estimate of $1.63 billion by 2.64% [1] - The company's EPS for the quarter was $1.31, up from $1.22 in the same quarter last year, surpassing the consensus estimate of $1.26 by 3.97% [1] Revenue Performance by End Markets - Pharmaceutical revenue reached $603 million, exceeding the average estimate of $572.63 million, with a year-over-year increase of 11.3% [4] - Academia and Government revenue was $135 million, below the average estimate of $145.13 million, representing a decline of 2.9% year-over-year [4] - Diagnostics and Clinical revenue amounted to $255 million, surpassing the average estimate of $247.93 million, with a year-over-year increase of 6.7% [4] - Agilent Crosslab Group net revenue was $713 million, exceeding the estimated $697.53 million, showing a significant year-over-year increase of 77.4% [4] - Food revenue was reported at $147 million, slightly above the average estimate of $146.05 million, with a year-over-year increase of 5.8% [4] - Environmental and Forensics revenue was $159 million, in line with the average estimate of $159.54 million, reflecting a year-over-year increase of 4.6% [4] - Chemical and advanced materials revenue was $369 million, slightly below the average estimate of $370.20 million, with a year-over-year increase of 1.9% [4] Stock Performance - Agilent's shares have returned +3.5% over the past month, compared to a +7.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]